A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)

Clinical trial NCT01794000 · TERMINATED

Trial details

NCT number: NCT01794000
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2013-04-01
Primary completion: 2015-07-01
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.